Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 9, keine Gesamtzahl für „lenalidomide“
Suchtreffer
Begriffe & Kennungen
Revlimid · 4.8 · The combination of lenalidomide with melphalan and prednisone in newly diagnosed multiple myeloma patients is
Eintrag öffnenRevlimid · 4.8 · The combination of lenalidomide with melphalan and prednisone in newly diagnosed multiple myeloma patients is
Eintrag öffnenRevlimid · 4.8 · The combination of lenalidomide with rituximab in follicular lymphoma is associated with a higher rate of grad
Eintrag öffnenRevlimid · 4.8 · The most commonly observed adverse reactions which occurred more frequently in the lenalidomide groups compare
Eintrag öffnenRevlimid · 4.8 · The most frequently observed adverse reactions which occurred more frequently in the lenalidomide arm compared
Eintrag öffnenRevlimid · 4.8 · The most serious adverse reactions observed more frequently in lenalidomide/dexamethasone than placebo/dexamet
Eintrag öffnenRevlimid · 4.8 · The observed adverse reactions which occurred more frequently with lenalidomide and dexamethasone than placebo
Eintrag öffnenRevlimid · 4.8 · The serious adverse reactions observed more frequently (≥ 5%) with lenalidomide maintenance than placebo were:
Eintrag öffnenRevlimid · 4.8 · Tumour flare reaction and tumour lysis syndrome In study MCL-002, approximately 10% of lenalidomide-treated pa
Eintrag öffnenRevlimid · 4.8 · • Newly diagnosed multiple myeloma: patients who are not eligible for transplant treated with lenalidomide in
Eintrag öffnenRevlimid · 4.8 · • Newly diagnosed multiple myeloma: patients who are not eligible for transplant treated with lenalidomide in
Eintrag öffnenSarclisa · 4.8 · Isatuximab in combination with bortezomib, lenalidomide, and dexamethasone (Isa-VRd) The Table 7 reports the p
Eintrag öffnenSarclisa · 4.8 · Laboratory Isatuximab + Bortezomib + Bortezomib + Lenalidomide + parameter Lenalidomide + Dexamethasone Dexame
Eintrag öffnenSarclisa · 4.8 · Laboratory Isatuximab + Bortezomib + Bortezomib + Lenalidomide + parameter Lenalidomide + Dexamethasone Dexame
Eintrag öffnenTepkinly · 4.8 · Adverse reactions occurring with epcoritamab in combination with lenalidomide and rituximab are listed in Tabl
Eintrag öffnenTepkinly · 4.8 · Adverse reactions occurring with epcoritamab in combination with lenalidomide and rituximab are listed in Tabl
Eintrag öffnenTepkinly · 4.8 · Epcoritamab in combination with lenalidomide and rituximab
Eintrag öffnenTepkinly · 4.8 · Epcoritamab in combination with lenalidomide and rituximab
Eintrag öffnenTepkinly · 4.8 · The safety of epcoritamab in combination with lenalidomide and rituximab was evaluated in M20-638, an open-lab
Eintrag öffnenTepkinly · 4.8 · The safety of epcoritamab in combination with lenalidomide and rituximab was evaluated in M20-638, an open-lab
Eintrag öffnen